MarketPeel
Insider Trading Intelligence
MF

Matthew W. Foehr

OABI
CHIEF EXECUTIVE OFFICER · OMNIAB, INC. · CIK 0001237556
FILING MIX · LIFETIME52%/48%
BUYS
91
SELLS
84
TOTAL VALUE
$30.49M
COMPANIES
3
ACTIVE SINCE
Feb 2019
HOLDINGS NOW
4,737,109
AVG SELL PX
$39.80
TRADE KIND
SHOWING 175 / 175
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
31 backtested trades · 8 horizons · 19 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Matthew W. Foehr, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d31+61.29%-0.40%+0.60%-1.00%-0.57%-0.74
14d31+77.42%-1.07%-0.54%-0.54%+0.34%-0.34
30d31+64.52%-4.43%-1.12%-3.31%-5.39%-1.13
60d31+87.10%-0.93%+1.14%-2.07%-7.64%-0.51
90d31(1 pending)+73.33%-1.58%+3.03%-4.61%-2.28%-0.95
180d31(3 pending)+53.57%-2.19%+8.76%-10.94%-11.56%
1y31(5 pending)+65.38%+17.02%+17.46%-0.44%-38.30%
2y31(10 pending)+57.14%+128.52%+34.55%+93.97%-54.12%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OABI · 4,439,736 shares · as of Apr 7, 2026
01,109,9342,219,8683,329,8024,439,7362023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 91 buys / 84 sellsCOVERAGE · 30 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OABI
OMNIAB, INC.
SALE
President and CEO
19,244$1.49$28.7K4,420,492Apr 7, 2026Apr 7, 2026View →
OABI
OMNIAB, INC.
SALE
President and CEO
36,459309,376Apr 7, 2026Apr 7, 2026View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
36,4594,439,736Apr 7, 2026Apr 7, 2026View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
156,250345,835Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
58,3334,434,120Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
SALE
President and CEO
30,843$1.71$52.7K4,403,277Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
SALE
President and CEO
58,333189,585Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
1,562,5001,562,500Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
SALE
President and CEO
20,754$1.70$35.3K4,375,787Feb 17, 2026Feb 17, 2026View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
36,4584,396,541Feb 16, 2026Feb 17, 2026View →
OABI
OMNIAB, INC.
SALE
President and CEO
36,458247,918Feb 16, 2026Feb 17, 2026View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
16,0000Jan 2, 2026Jan 5, 2026View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
16,000$35.11$561.7K132,036Jan 2, 2026Jan 5, 2026View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
16,000$3.33$53.3K148,036Jan 2, 2026Jan 5, 2026View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,40020,400Jan 2, 2026Jan 5, 2026View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,150135,186Jan 2, 2026Jan 5, 2026View →
OABI
OMNIAB, INC.
SALE
President and CEO
13,666$1.96$26.8K4,360,083Dec 8, 2025Dec 9, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
26,554284,376Dec 7, 2025Dec 9, 2025View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
26,5544,373,749Dec 7, 2025Dec 9, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
540,540$1.85$1000.0K4,341,987Aug 26, 2025Aug 26, 2025View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
20,7860Apr 11, 2025Apr 14, 2025View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
20,786$8.00$166.3K132,036Apr 11, 2025Apr 14, 2025View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
36,4583,815,618Apr 7, 2025Apr 7, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
36,458310,930Apr 7, 2025Apr 7, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
19,382$2.00$38.8K3,796,236Apr 7, 2025Apr 7, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
19,522$3.67$71.6K3,779,160Feb 19, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
1,050,0001,050,000Feb 18, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
175,000347,388Feb 18, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
13,964$3.68$51.4K3,798,682Feb 18, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
36,458172,388Feb 16, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
36,4583,812,646Feb 16, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
26,5493,776,188Feb 15, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
26,549208,846Feb 15, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
41,811$3.24$135.5K3,749,639Jan 21, 2025Jan 22, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
77,0033,791,450Jan 17, 2025Jan 22, 2025View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
18,80018,800Jan 2, 2025Jan 6, 2025View →
OABI
OMNIAB, INC.
SALE
President and CEO
13,634$4.13$56.3K3,714,447Dec 9, 2024Dec 10, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
26,5553,728,081Dec 7, 2024Dec 10, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
26,555235,395Dec 7, 2024Dec 10, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
31,074$3.68$114.4K3,630,240Nov 25, 2024Nov 26, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
31,074155,371Nov 25, 2024Nov 26, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
68,360396,484Nov 25, 2024Nov 26, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
68,360$3.75$256.4K3,698,600Nov 25, 2024Nov 26, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
41,015464,844Jun 27, 2024Jun 27, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
41,015$3.75$153.8K3,599,166Jun 27, 2024Jun 27, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
18,644$3.68$68.6K3,558,151Jun 27, 2024Jun 27, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
18,644186,445Jun 27, 2024Jun 27, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
240,000$4.42$1.06M3,536,665May 24, 2024May 28, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
18,477$5.31$98.1K3,170,397Apr 7, 2024Apr 9, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
36,4583,188,874Apr 7, 2024Apr 9, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
36,458261,950Apr 7, 2024Apr 9, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
150,391505,859Mar 27, 2024Mar 29, 2024View →
OABI
OMNIAB, INC.
SALE
President and CEO
93,222205,089Mar 27, 2024Mar 29, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
150,391$3.75$564.0K3,152,416Mar 27, 2024Mar 29, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
93,222$3.68$343.1K3,002,025Mar 27, 2024Mar 29, 2024View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
225,000$5.19$1.17M2,908,803Mar 22, 2024Mar 25, 2024View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
109,375298,408Feb 16, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
656,250656,250Feb 16, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
10,7702,676,164Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
10,770215,591Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
26,558189,033Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
5,459$5.54$30.2K2,670,705Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
13,460$5.54$74.6K2,683,803Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
26,5582,697,263Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
13,221$6.25$82.6K2,665,394Jan 2, 2024Jan 3, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
33,173226,361Jan 2, 2024Jan 3, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
33,1732,678,615Jan 2, 2024Jan 3, 2024View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jan 2, 2024Jan 4, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
200,000$5.05$1.01M2,645,442Dec 12, 2023Dec 13, 2023View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
26,556259,534Dec 7, 2023Dec 11, 2023View →
OABI
OMNIAB, INC.
SALE
Chief Executive Officer
9,184$4.85$44.5K2,445,442Dec 7, 2023Dec 11, 2023View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
26,5562,454,626Dec 7, 2023Dec 11, 2023View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
95,000$4.27$405.5K2,427,919Nov 10, 2023Nov 13, 2023View →
OABI
OMNIAB, INC.
PURCHASE
President and CEO
45,000$5.48$246.6K2,332,919Aug 14, 2023Aug 15, 2023View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
115,000$4.52$519.8K2,574,009Jun 9, 2023Jun 12, 2023View →
OABI
OMNIAB, INC.
PURCHASE
Chief Executive Officer
440,000$3.40$1.50M2,438,414May 12, 2023May 15, 2023View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
656,250656,250Apr 7, 2023Apr 11, 2023View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
109,3751,998,414Apr 7, 2023Apr 11, 2023View →
OABI
OMNIAB, INC.
SALE
President & CEO
9,184$3.80$34.9K1,896,941Feb 15, 2023Feb 17, 2023View →
OABI
OMNIAB, INC.
SALE
President & CEO
3,725$3.80$14.2K1,893,216Feb 15, 2023Feb 17, 2023View →
OABI
OMNIAB, INC.
SALE
President & CEO
4,177$3.80$15.9K1,889,039Feb 15, 2023Feb 17, 2023View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jan 3, 2023Jan 4, 2023View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
79,6651,906,125Jan 3, 2023Jan 5, 2023View →
OABI
OMNIAB, INC.
SALE
President & CEO
11,624$3.66$42.5K1,826,460Dec 28, 2022Dec 30, 2022View →
OABI
OMNIAB, INC.
PURCHASE
President & CEO
150,000$3.77$564.8K1,838,084Dec 12, 2022Dec 14, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
298,311298,311Dec 7, 2022Dec 9, 2022View →
OABI
OMNIAB, INC.
SALE
President & CEO
17,266$3.35$57.8K1,688,084Dec 1, 2022Dec 5, 2022View →
OABI
OMNIAB, INC.
PURCHASE
President & CEO
300,000$3.39$1.02M1,705,350Nov 30, 2022Dec 1, 2022View →
OABI
OMNIAB, INC.
PURCHASE
President & CEO
100,000$2.76$276.2K1,405,350Nov 9, 2022Nov 9, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
1,431,6183,296,665Nov 1, 2022Apr 23, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
34,2140Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
142,168142,168Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
1,305,3501,305,350Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
56,23356,233Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
86,79086,790Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
298,311298,311Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
172,768172,768Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
146,325146,325Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
111,038111,038Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
104,231104,231Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
270,595270,595Nov 1, 2022Nov 3, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
20,304162,187Nov 1, 2022Nov 3, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,137182,491Jun 10, 2022Jun 14, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
2,500$82.76$206.9K173,354May 13, 2022May 13, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
34,21434,214May 5, 2022May 9, 2022View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
45,000$2.47$111.2K111,250May 2, 2022May 3, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,090$123.68$134.8K170,854Feb 15, 2022Feb 16, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,234$123.68$152.6K173,166Feb 15, 2022Feb 16, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,222$123.68$151.1K171,944Feb 15, 2022Feb 16, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
3,188$113.68$362.4K174,400Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,396179,525Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,937$113.68$220.2K177,588Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,604172,129Jan 26, 2022Jan 28, 2022View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jan 3, 2022Jan 5, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
1,028$100.38$103.2K166,525Nov 11, 2021Nov 12, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
11,160$163.02$1.82M166,525Nov 11, 2021Nov 12, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,02824,348Nov 11, 2021Nov 12, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
11,160$21.92$244.6K177,685Nov 11, 2021Nov 12, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
11,1600Nov 11, 2021Nov 12, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
8,84011,160Aug 4, 2021Aug 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,14225,938Aug 4, 2021Aug 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
8,840$109.67$969.5K164,355Aug 4, 2021Aug 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
8,840$21.92$193.8K173,195Aug 4, 2021Aug 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
1,142$85.79$98.0K165,497Aug 4, 2021Aug 5, 2021View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
20,000$5.69$113.8K66,250Jun 10, 2021Jun 10, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALEGRANT
Gift
2,500162,600May 28, 2021Jun 1, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
1,755$56.26$98.7K164,355May 28, 2021Jun 1, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,75540,358May 28, 2021Jun 1, 2021View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
20,000$1.50$30.0K46,250Mar 22, 2021Mar 25, 2021View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
20,0000Mar 22, 2021Mar 25, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
641$172.46$110.5K167,557Feb 15, 2021Feb 18, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,235$172.46$213.0K166,322Feb 15, 2021Feb 18, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,222$172.46$210.7K165,100Feb 15, 2021Feb 18, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
44,547$21.92$976.5K212,745Feb 4, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
1,000$74.42$74.4K168,198Feb 4, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
44,54720,000Feb 4, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
44,547$176.86$7.88M168,198Feb 4, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,00063,210Feb 4, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,595167,198Feb 3, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,13613,136Feb 3, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,911158,324Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,604162,875Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
2,272$156.01$354.5K160,603Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,053$156.01$164.3K157,271Jan 25, 2021Jan 27, 2021View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jan 4, 2021Jan 6, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7864,547Aug 24, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
78$110.89$8.6K155,413Aug 24, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
78$21.92$1.7K155,491Aug 24, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7,225$112.88$815.5K155,413Aug 21, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
7,225$14.47$104.5K162,638Aug 21, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7,2250Aug 21, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
790$74.42$58.8K155,413Aug 21, 2020Aug 25, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
79064,210Aug 21, 2020Aug 25, 2020View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
13,000$7.35$95.5K26,250Jun 30, 2020Jun 30, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
2,00064,625Mar 13, 2020Mar 13, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
2,000$21.92$43.8K157,449Mar 13, 2020Mar 13, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,70666,625Feb 27, 2020Feb 27, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7,225$110.00$794.8K153,743Feb 27, 2020Feb 27, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7,2257,225Feb 27, 2020Feb 27, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
7,225$14.47$104.5K160,968Feb 27, 2020Feb 27, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
1,706$21.92$37.4K155,449Feb 27, 2020Feb 27, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,170$97.23$113.8K153,743Feb 15, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
447$97.23$43.5K154,913Feb 15, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
869$97.23$84.5K155,360Feb 15, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7,22514,450Feb 14, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
7,225$14.47$104.5K163,454Feb 14, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
7,225$95.84$692.5K156,229Feb 14, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
33,21033,210Feb 13, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
49668,331Feb 13, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
President and COO
496$21.92$10.9K148,833Feb 13, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,396156,229Feb 13, 2020Feb 18, 2020View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jan 2, 2020Jan 3, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
938$120.86$113.4K124,615Feb 15, 2019Apr 24, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
642$120.86$77.6K122,727Feb 15, 2019Apr 24, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
President and COO
1,246$120.86$150.6K123,369Feb 15, 2019Apr 24, 2020View →
Other insiders · OABI
Loading peer insiders…
About this filer
CIK 0001237556
ROLE
Chief Executive Officer
PRIMARY
OABI
COMPANIES
3
ACTIVE SINCE
Feb 2019
MARKETPEEL · /INSIDER/0001237556DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback